BIMODALITY OF PLASMA APOLIPOPROTEIN-B LEVELS IN FAMILIAL COMBINED HYPERLIPIDEMIA

被引:63
作者
AUSTIN, MA
HOROWITZ, H
WIJSMAN, E
KRAUSS, RM
BRUNZELL, J
机构
[1] UNIV WASHINGTON,SCH PUBL HLTH & COMMUNITY MED,DEPT EPIDEMIOL,SEATTLE,WA 98195
[2] UNIV CALIF BERKELEY,LAWRENCE BERKELEY LAB,DIV RES MED & RADIAT BIOPHYS,MOLEC MED RES PROGRAM,BERKELEY,CA 94720
关键词
APOLIPOPROTEINS; COMMINGLING; HYPERLIPIDEMIA; LOW DENSITY LIPOPROTEINS; GENETICS;
D O I
10.1016/0021-9150(92)90011-5
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
To investigate possible genetic influences on plasma apolipoprotein (apo) B levels in familial combined hyperlipidemia (FCHL), commingling analysis was performed on data from seven large kindreds, including 183 individuals. The overall frequency distribution of apo B was skewed and was compatible with the presence of two normally distributed subdistributions (mean values, 117 and 172 mg/dl). The analysis was repeated after stratification of individuals by low density lipoprotein (LDL) subclass phenotype. Among subjects with phenotype A (predominance of large, buoyant LDL), a single apo B distribution was found (mean, 115 mg/dl). Among subjects with phenotype B (predominance of small, dense LDL), the distribution was bimodal, with mean values, 116 and 167 mg/dl, similar to the unstratified data set. Thus the skewing of the overall apo B distribution in FCHL family members may be due to a distinct subset of individuals with phenotype B who are genetically susceptible to even higher elevations of apo B. The higher apo B/phenotype B subjects also showed significantly higher levels of triglyceride and LDL-cholesterol than the lower apo B/phenotype B subjects. The lower apo B/phenotype B subjects had higher triglyceride and lower LDL-cholesterol than the phenotype A subjects. The enhanced information regarding apo B and lipid levels in the three subgroups of individuals identified here may facilitate a better understanding of genetic susceptibility to coronary heart disease.
引用
收藏
页码:67 / 77
页数:11
相关论文
共 33 条
[1]
IMMUNOASSAY OF HUMAN PLASMA APOLIPOPROTEIN-B [J].
ALBERS, JJ ;
CABANA, VG ;
HAZZARD, WR .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1975, 24 (12) :1339-1351
[2]
LINKAGE AND SEGREGATION ANALYSES OF APOLIPOPROTEIN-A1 AND APOLIPOPROTEIN-B, AND LIPOPROTEIN CHOLESTEROL LEVELS IN A LARGE PEDIGREE WITH EXCESS CORONARY HEART-DISEASE - THE BOGALUSA HEART-STUDY [J].
AMOS, CI ;
ELSTON, RC ;
SRINIVASAN, SR ;
WILSON, AF ;
CRESANTA, JL ;
WARD, LJ ;
BERENSON, GS .
GENETIC EPIDEMIOLOGY, 1987, 4 (02) :115-128
[3]
[Anonymous], 1971, STAT PRINCIPLES EXPT
[4]
AUSTIN MA, 1988, AM J HUM GENET, V43, P838
[5]
INHERITANCE OF LOW-DENSITY-LIPOPROTEIN SUBCLASS PATTERNS IN FAMILIAL COMBINED HYPERLIPIDEMIA [J].
AUSTIN, MA ;
BRUNZELL, JD ;
FITCH, WL ;
KRAUSS, RM .
ARTERIOSCLEROSIS, 1990, 10 (04) :520-530
[6]
AUSTIN MA, 1988, JAMA-J AM MED ASSOC, V260, P1917
[7]
ATHEROGENIC LIPOPROTEIN PHENOTYPE - A PROPOSED GENETIC-MARKER FOR CORONARY HEART-DISEASE RISK [J].
AUSTIN, MA ;
KING, MC ;
VRANIZAN, KM ;
KRAUSS, RM .
CIRCULATION, 1990, 82 (02) :495-506
[8]
Bachorik P S, 1986, Methods Enzymol, V129, P78
[9]
BEATY TH, 1986, AM J HUM GENET, V38, P492
[10]
MYOCARDIAL-INFARCTION IN FAMILIAL FORMS OF HYPERTRIGLYCERIDEMIA [J].
BRUNZELL, JD ;
SCHROTT, HG ;
MOTULSKY, AG ;
BIERMAN, EL .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1976, 25 (03) :313-320